Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation (TENS): A review

Herz

Volumn 24, Issue 2, 1999, Pages 114-125

  Börjesson, Mats ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Afferent stimulation; Angina pectoris; Spinal cord stimulation (SCS); Transcutaneous electrical nerve stimulation (TENS); Unstable angina; Visceral pain

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; HUMAN; REVIEW; SPINAL CORD STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; UNSTABLE ANGINA PECTORIS;

EID: 0344224207     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03043850     Document Type: Review

References (130)

1. Andrews TC, Raby K, Barry J, et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 1997;95:324-8.
2. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
3. Areskog M, Tibbling L, Wranne B. Non-infarction coronary unit patients. Acta Med Scand 1981;209:51-7.
4. Augustinsson L, Linderoth B, Mannheimer C. Spinal cord stimulation in various ischemic conditions In: Illis L, ed. Spinal cord dysfunction, Vol III. Functional stimulation. Oxford University Press, Oxford, 1992:272-95.
5. Baker DG, Coleridge HM, Coleridge JCG, et al. Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat. J Physiol 1980; 306:519-36.
6. Barish CF, Castell DO, Richter JE. Graded esophageal balloon distention-a new provocative test for non-cardiac chest pain. Dig Dis Sci 1986;31:1292-8.
7. Bates JAV, Nathan PW. Transcutaneous electrical nerve stimulation for chronic pain. Anaesthesia 1980;35:817-22.
8. Becker RC, Cannon CP, Bovill EG, et al. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave myocardial infarction (TIMI IIIB trial). Am J Cardiol 1996;78:142-7.
9. Bennett JR, Atkinson M. The differentiation between oesophageal and cardiac pain. Lancet 1966;2:1123-7.
10. Bishop VS, Malliani A, Thorén P. Cardiac mechanoreceptors. In: Shepherd JT, Abboud FM, Geiger SR. Handbook of physiology, Vol. III. Washington: Am Physiological Soc 1983:497-55.
11. Blackwell JN, Castell DO. Oesophageal chest pain: a point of view. Gut 1984;25:1-6.
12. Blair RW, Weber RN, Foreman RD. Responses of thoracic spinothalamic neurones to intracardiac injection of bradykinin in the monkey. Circ Res 1982;51:83-94.
13. Bortolotti M, Bacchelli S, Esposti SD, et al. Angina-like chest pain of esophageal origin: a possible side-effect of the chronic anti-anginal therapy. Gastroenterology 1990:A 24.abstract.
14. Bosch X, Theroux P, Waters D, et al. Early post-infarction ischemia: Clinical, angiographic, and prognostic significance. Circulation 1987;75:988-95.
15. Börjesson M, Eriksson P, Dellborg, et al. Transcutaneous electrical nerve stimulation in unstable angina pectoris. Coron Art Dis 1997;8:543-50.
16. Börjesson M, Pilhall M, Eliasson T, et al. Esophageal dysfunction in syndrome X. Am J Cardiol 1998;82:1187-91.
17. Caffrey JL, Gaugl JF, Jones CE. Local endogenous opiate activity in dog myocardium: Receptor blockade with naloxone. Am J Physiol 1985;248:H382-8.
18. Campbell JA. A critical appraisal of the electrical output characteristics of ten transcutaneous nerve stimulators. Clin Phys Measurement 1982;3:141-50.
19. Campbell JN, Taub A. Local analgesia from percutaneous electrical stimulation. Arch of Neurol 1973;28:347-350.
20. Cannon CP, McCabe CH, Stone PH, et al. Circadian variation in the onset of unstable angina and non-Q wave acute myocardial infarction (the TIMI III registry and TIMI IIIB). Am J Cardiol 1997;79:253-8.
21. Cannon RO. The sensitive heart. A syndrome of abnormal cardiac pain perception. JAMA 1995;273:883-7.
22. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 1994;74:95-138.
23. Cervero F, Lumb BM. Bilateral inputs and supraspinal control of viscerosomatic neurones in the lower thoracic spinal cord of the cat. J Physiol 1988;403:221-37.
24. Cervero F, Tattersall JEH. Somatic and visceral sensory integration in the thoracic spinal cord. In: Cervero F, Morrison JFB Visceral sensation. Progress in brain research. Vol 67 .Amsterdam: Elsevier 1986:189-205.
25. Chandler MJ, Brennan TJ, Garrison DW, et al. A mechanism of cardiac pain suppression by spinal cord stimulation: implications for patients with angina pectoris. Eur Heart J 1993;14:96-105.
26. Chauhan A, Mullins PA, Thuraisingham SI, et al. Effect of transcutaneous electrical nerve stimulation on coronary blood flow. Circulation 1994;89:694-702.
27. Chauhan A, Petch MC, Schofield PM. Effect of oesophageal acid instillation on coronary blood flow. Lancet 1993;341:1309-10.
28. Cherniack NS, Runold M, Prabhakar NR, et al. Effect of adenosine on vagal sensory pulmonary afferents. Fed Proc 1987;46:825.
29. Cohn PF. Silent myocardial ischemia in patients with a defective anginal warning system. Am J Cardiol 1980;45:697-702.
30. Cook AW, Oygar A, Baggenstos P, et al. Vascular disease of extremities-Electric stimulation of spinal cord and posterior roots. NY State J Med 1976;76:366-8.
31. Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol 1990;75:656-60.
32. DeLandsheere C, Mannheimer C, Habets A, et al. Effect of spinal cord stimulation on regional myocardial perfusion assessed by positron emission tomography. Am J Cardiol 1992;69: 1143-9.
33. Deanfield JE, Shea M, Ribiero P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984;54:1195-200.
34. Deedwania PC, Carbajal EV. Silent myocardial ischemia-a clinical perspective. Arch Intern Med 1991;151:2373-82.
35. Deedwania PC, Carbajal EV, Nelson JR, et al. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol 1991;17:963-9.
36. DeJongste MJL, Haaksma J, Hautvast RWM, et al. Effects of spinal cord stimulation on myocardial ischemia during daily life in patients with severe coronary artery disease. Br Heart J 1993;71:413-8.
37. DeMeester TR, O'Sullivan GC, Bermudez G, et al. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg 1982;196:488-98.
38. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
39. Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983;1:940-5.
40. Edlund A, Fredholm BB, Patrignani P, et al. Release of two vasodilators - adenosine and prostacyclin - from isolated rabbit hearts during controlled hypoxia. J Physiol 1983;340:487-501.
41. Eliasson T, Jern S, Augustinsson L-E, et al. Safety aspects of spinal cord stimulation in severe angina pectoris. Coron Art Dis 1994;5:845-50.
42. Eliasson T, Mannheimer C, Waagstein F, et al. Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing induced angina pectoris. Cardiology 1998,89:170-7.
43. Epstein SE, Quyyumi AA, Bonow RO. Myocardial ischemia: Silent or symptomatic. N Engl J Med 1988;318:1038-43.
44. Eriksson MBE, Rosén I, Sjölund B. Thermal sensitivity in healthy subjects is decreased by a central mechanism after TNS. Pain 1985;22:235-42.
45. Fazzini PF, Prati PL, Rovelli F, et al. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am J Cardiol 1993;72:1383-8.
46. Foreman RD. Spinothalamic tract and cardiac afferents. In: Lown B, Malliani A, Prosdocimi M. Fidia research series, Vol 5. Padova: Liviana Press, 1986:169-81.
47. Friedman M, Breall WS, Goodwin ML, et al. Effect of type A behavioral counseling on frequency of episodes of silent myocardial ischemia in coronary patients. Am Heart J 1996;132:933-7.
48. Garcia-Pulido J, Patel PH, Hunter WC, et al. Esophageal contribution to chest pain in patients with coronary artery disease. Chest 1990;98:806-10.
49. Geft IL, Fishbein MC, Ninomiya K. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation 1982;66:1150-3.
50. Gelford M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical manometric and radionuclide evaluation. Gastroenterology 1982;83:963-9.
51. Gilbert NC, LeRoy GV, Fenn GK. The effect of distention of abdominal viscera on the blood flow in the circumflex branch of the left coronary artery of the dog. Am Heart J 1940;20:519-24.
52. Glazier JJ, Chierchia S, Brown MJ, et al. Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris. Am J Cardiol 1986;58:667-72.
53. Gottlieb S, Weisfeldt M, Ouyang P, et al. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind placebo-controlled trial. Circulation 1986;73:331-7.
54. Gottlieb SO, Gottlieb SH, Achuff SC, et al. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 1988;259:1030-5.
55. Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214-9.
56. Hautwast RWM, Blanksma PK, DeJongste MJL, et al. Effect of spinal cord stimulation on myocardial flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol 1996;77:462-7.
57. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: An overview. Br Med J 1989;299:1187-92.
58. Hoberg E. Symptomatic versus asymptomatic ischemic episodes during Holter monitoring: patterns of high resolution trend recordings of ST segment and heart rate. In: von Arnim T, Maseri A. Silent ischemia. Darmstadt: Steinkopff, 1987:125-30.
59. Jacobs MJMH, Jörning PJG, Beckers RCY, et al. Foot salavage and improvement of microvacular blood flow as a result of epidural spinal cord electrical stimulation. J Vasc Surg 1990;12:354-60.
60. Janes RD, Brandys JC, Hopkins DA, et al. Anatomy of human extrinsic cardiac nerves and ganglia. Am J Cardiol 1986;57: 299-309.
61. Janssens J, Vantrappen G, Ghillebert G. 24-hour recording of esophageal pressure and pH in patients with noncardiac chest pain. Gastroenterology 1986;90:1978-84.
62. Jivegård LEH, Augustinsson L-E, Holm J, et al. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg 1995;9:421-5.
63. Johnson MI, Ashton CH, Bousfield DR, et al. Analgesic effects of different frequencies of transcutaneous electrical nerve stimulation on cold induced pain in normal subjects. Pain 1989;39:231-6.
64. Johnson MI, Ashton CH, Thompson JW. An in-depth study of long-term users of transcutaneous electrical nerve stimulation (TENS). Implications for clinical use of TENS. Pain 1991;44:221-9.
65. Kaada B. Promoted healing of chronic ulceration by transcutaneous nerve stimulation (TNS). VASA 1983;12:262-9.
66. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. N Engl J Med 1984;311:1144-7.
67. Kaplan B, Peled Y, Pardo J, et al. Transcutaneous electrical nerve stimulation (TENS) as a relief for dysmenorrhea. Clin Exp Obstet Gynecol 1994;21:87-90.
68. Katon W, Vitaliano DD, Russo J, et al. Panic disorder: Epidemiology in primary care. J Fam Pract 1986;23:233-9.
69. Katz PO, Dalton CB, Richter JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia-results of three years' experience with 1161 patients. Ann Intern Med 1987;106: 593-7.
70. Keele CA, Armstrong D. Substances producing pain and itch. London: Arnold, 1964:329-37.
71. Kellermann JJ, Braunwald E. Silent myocardial ischemia: a critical appraisal. Basel: Karger, 1990.
72. Knatterud GL, Bourassa MG, Pepine CJ, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol 1994;24:11-20.
73. Lam HGT, Dekker W, Kan G, et al. Acute noncardiac chest pain in a coronary care unit. Gastroenterology 1992;102:453-60.
74. Lindahl B, Andrén B, Ohlsson J, et al. Risk stratification in unstable coronary artery disease. Additive value of troponin T determination and pre-discharge exercise tests. Eur Heart J 1997;18: 762-70.
75. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
76. Linderoth B, Fedorcsak I, Meyerson BA. Peripheral vasodilatation after spinal cord stimulation: animal studies of putative effector mechanisms. Neurosurgery 1991;28:187-95.
77. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
78. Malliani A. The conceptualization of cardiac pain as a nonspecific and unreliable alarm system. In: Gebhart GF. Visceral pain, Vol 5. Seattle: IASP Press, 1995:63-74.
79. Malliani A, Brown AM. Reflexes arising from coronary receptors. Brain Res 1970;24:352-5.
80. Malliani A, Lombardi F. Consideration of the fundamental mechanisms eliciting cardiac pain. Am Heart J 1982;103:575-8.
81. Malliani A, Pagani M, Lombardi F. Positive feedback reflexes. In: Zanchetti A, Tarazi RC. Handbook of hypertension, Vol 8. Pathophysiology of hypertension. Amsterdam: Elsevier, 1986: 69-81.
82. Malliani A, Recordati G, Schwartz PJ. Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings. J Physiol 1973;229:457-69.
83. Mannheimer C, Carlsson C-A, Vedin A, et al. Transcutaneous electrical nerve stimulation (TENS) in angina pectoris. Pain 1986;26:291-300.
84. Mannheimer C, Carlsson CA, Emanuelsson H, et al. The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation 1985;71:308-16.
85. Mannheimer C, Carlsson CA, Ericson K, et al. Transcutaneous electrical nerve stimulation in severe angina pectoris. Eur Heart J 1982;3:297-302.
86. Mannheimer C, Eliasson T, Andersson B, et al. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. Br Med J 1993;307:477-80.
87. Marcassa C, Galli M, Baroffio C, et al. Ischemic burden in silent and painful myocardial ischemia: A quantitive exercise sestamibi tomographic study. J Am Coll Cardiol 1997;29:948-54.
88. Martin SJ, Gorham LW. Cardiac pain. An experimental study with reference to the tension factor. Arch Intern Med 1938;62: 840-52.
89. Maseri A, Crea F, Kaski JC, et al. Mechanisms and significance of cardiac ischemic pain. Prog Cardiovasc Dis 1992;35:1-18.
90. Mellow MH, Simpson AG, Watt L, et al. Esophageal acid perfusion in coronary artery disease. Induction of myocardial ischemia. Gastroenterology 1983;85:306-12.
91. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-9.
92. Milsom I, Hedner N, Mannheimer C. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea. Am J Obstet Gynecol 1994;170:123-9.
93. Mulcahy D, Keegan J, Crean P, et al. Silent myocardial ischemia in chronic stable angina: a study of its frequency and characteristics in 150 patients. Br Heart J 1988;60:417-23.
94. Mulcahy R, Awadhi AH, deBulleor M, et al. Natural history and prognosis of unstable angina. Am Heart J 1985;109:753-8.
95. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987;57:23C-30C.
96. Norrsell H, Eliasson T, Mannheimer C, et al. Effects of pacing-induced myocardial stress and spinal cord stimulation on whole body and cardiac norepinephrine spillover. Eur Heart J 1997; 18:1890-6.
97. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The atenolol silent ischemia study (ASIST). Circulation 1994;90:762-8.
98. Perl ER. Is pain a specific sensation? J Psychiat Res 1971;8: 273-87.
99. Perna G, Stanislao M, Salavatori MP, et al. Basal plasma beta-endorphin and beta-lipotropin in patients with symptomatic and asymptomatic myocardial ischemia. Cardiologia 1988;33:765-9.
100. Richter JE. Investigation and management of non-cardiac chest pain. Baillière's Clin Gastroenterol 1991;5:281-306.
101. Richter JE. The esophagus and noncardiac chest pain. In: Castell DO. The esophagus, 2nd edn. Little, Brown and Company, Boston, 1995: 699-724.
102. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:845-52.
103. Ros E, Armengol X, Grande L, et al. Chest pain at rest in patients with coronary artery disease. Dig Dis Sci 1997;42:1344-53.
104. Ruch TC. Visceral sensation and referred pain. In: Howell's textbook of physiology. Philadelphia: Saunders 1946:385-401.
105. Sanderson JE, Woo KS, Chung HK, et al. The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X. Coron Art Dis 1996;7:547-52.
106. Schuster EH, Bulkley BH. Early post-infarction angina: Ischemia at a distance and ischemia in the infarct zone. N Engl J Med 1981;305:1101-5.
107. Serneri GGN, Prisco D, Martini F, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806-12.
108. Singh S, Richter JE, Hewson EG, et al. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med 1992;117:824-30.
109. Stone PH, Gibson RS, Glasser SP, et al. Comparison of propranolol, diltiazem and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation 1990;82:1962-72.
110. Sylvén C. Angina pectoris. Clinical characteristics, neurophysiological and molecular mechanisms - a review. Pain 1989;36: 145-67.
111. Sylvén C, Beermann B, Jonzon B, et al. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J 1986;293:227-30.
112. Sylvester K, Kendall GPN, Lennard-Jones JE. Treatment of functional abdominal pain by transcutaneous nerve stimulation. Br Med J 1986;293:481-2.
113. Taylor P, Hallett M, Flaherty L. Treatment of osteoarthritis of the knee with transcutaneous electrical nerve stimulation. Pain 1981;11:233-40.
114. TenVaarweerk IAM, Jessurun GAJ, Hautwast R, et al. Mortality and morbidity in patients treated with spinal cord stimulation for intractable angina pectoris. Heart (accepted for publication).
115. Thompson SG, Kienast J, Pyke SDM, et al. Homeostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
116. Thorsteinsson G, Stonnington HH, Stillwell GK, et al. Transcutaneous electrical stimulation: a double-blind trial of its efficacy for pain. Arch Phys Med Rehab 1977;58:8-13.
117. Tijssen JG, Lubsen J. Early treatment of unstable angina with nifedipine and metoprolol - the HINT trial. J Cardiovasc Pharmacol 1988;12:Suppl 1:S71-7.
118. Toss H, Lindahl B, Siegbahn A, et al. Prognostic influence of increased fibrinogen and C-reactive protein level in unstable coronary artery disease. Circulation 1997;96:4201-10.
119. Traube M, Albibi R, McCallum RW. High-amplitude peristaltic esophageal contractions associated with chest pain. JAMA 1983;250:2655-9.
120. Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988;62:661-4.
121. VanderArk GD, McGrath KA. Transcutaneous electrical stimulation in treatment of postoperative pain. Am J Surg 1975; 130:338-40.
122. Vantrappen G, Janssens J. Angina and oesophageal pain - a gastroenterologist's point of view. Eur Heart J 1986;7:828-34.
123. vonArnim T. Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis. Results of the Total ischemic burden bisoprolol study (TIBBS). Follow up. J Am Coll Cardiol 1996;28:20-4.
124. Wall PD, Melzack R. Textbook of pain, 3rd edn. New York: Churchill Livingstone, 1997.
125. Walsh DM. TENS Clinical applications and related theory. New York: Churchill Livingstone, 1997.
126. Walsh DM, Foster NF, Baxter GD, et al. Transcutaneous electrical nerve stimulation. Relevance of stimulation parameters to neurophysiological and hypoalgesic effects. Am J Phys Med Rehab 1995;74:199-206.
127. Webb SC, Poole-Wilson PA. Potassium exchange in the human heart during atrial pacing and myocardial ischaemia. Br Heart J 1986;55:554-9.
128. Weidinger F, Hammerle A, Sochor H, et al. Role of beta-endorphins in silent myocardial ischemia. Am J Cardiol 1986;58: 428-30.
129. White CW. Clinical applications of Doppler coronary flow reserve measurements. Am J Cardiol 1993;71:10D-6D.
130. Willerson JT, Golino P, Eidt J, et al. Specific platelet mediators and unstable coronary artery lesions. Circulation 1989;80: 198-205.